BMC Ophthalmology,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: April 28, 2023
To
evaluate
changes
in
objective
optical
quality
following
intense
pulsed
light
(IPL)
treatment
combined
with
meibomian
gland
(MG)
expression
(MGX)
patients
MG
dysfunction
(MGD).This
retrospective
cross-sectional
study
included
MGD-related
dry
eye
disease
(DED)
who
received
IPL
between
March
and
December
2021
at
Kim's
Eye
Hospital,
Seoul,
Republic
of
Korea.
Each
patient
underwent
four
sessions
using
Lumenis
M22
(Lumenis
Ltd.,
Yokneam,
Israel)
MGX
three-week
intervals.This
90
eyes
from
45
MGD.
The
mean
age
was
52.3
±
16.1
years
(range,
20-75
years),
53.3%
(24/45)
were
female.
Compared
the
baseline,
all
clinical
symptoms
signs
significantly
improved
after
MGX.
All
parameters
obtained
an
analysis
system
(OQAS:
Visiometrics,
Castelldefels,
Spain)
have
over
baseline
(p
<
0.001).In
MGD,
DED.
Small Methods,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
The
conventional
carbonization
process
for
synthesizing
hard
carbons
(HCs)
requires
high-temperature
furnace
operations
exceeding
1000
°C,
leading
to
excessive
energy
consumption
and
lengthy
processing
times,
which
necessitates
the
exploration
of
more
efficient
synthesis
methods.
This
study
demonstrates
rapid
preparation
HC
anodes
using
intense
pulsed
light
(IPL)-assisted
photothermal
without
prolonged
complex
typical
traditional
A
composite
film
microcrystalline
cellulose
(MCC)
single-walled
carbon
nanotubes
(SWCNTs)
is
carbonized
at
high
temperatures
in
less
than
1
min.
SWCNTs
efficiently
absorbed
energy,
enabling
ultrafast
heating
eliminating
need
prolonged,
high-energy
furnace-based
processes.
IPL-assisted
exhibited
excellent
electrochemical
performance,
with
an
initial
desodiation
capacity
260.4
mAh
g⁻¹anode
97.5%
retention
after
200
cycles.
These
results
are
comparable
those
achieved
processes,
such
as
carbonizing
1200
validating
effectiveness
Additionally,
surface
structural
analyses
revealed
development
pseudo-graphitic
domains,
crucial
enhanced
sodium-ion
storage.
research
highlights
a
viable,
time-efficient,
energy-saving
alternative
methods,
offering
sustainable
pathway
large-scale
production
future
battery
technologies.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(2), P. e0316935 - e0316935
Published: Feb. 28, 2025
Purpose
This
study
aimed
to
investigate
changes
in
dry
eye
disease
(DED)
parameters
and
tear
film
lipid
layer
distribution
after
intensive
pulse
light
(IPL)
combined
with
meibomian
gland
expression
(MGX)
patients
dysfunction
(MGD).
Methods
retrospective
included
218
diagnosed
MGD
who
underwent
IPL
MGX.
Various
DED
parameters,
including
thickness
(LLT),
were
measured
using
a
Placido
disc
analyzer
slit
lamp.
Inferior
corneal
images
quantified
divided
into
upper,
lower,
nasal,
temporal
quadrants,
further
subdivision
six
parts
from
top
bottom
Python.
Results
The
ocular
surface
index,
expressibility,
quality
scores
significantly
improved
three
treatment
sessions.
Slit-lamp-measured
also
improved,
excluding
the
fluorescein-stained
meniscus
height.
Redness
nasal
limbal
bulbar
conjunctivae
decreased.
mean
LLT
tended
increase
treatment.
upper
half
of
images,
but
not
lower
half,
increased
significantly,
difference
between
two
halves
decreasing
34.46
±
15.73
30.27
14.63
nm
(p
=
0.031).
When
vertical
was
analyzed
by
equal
bottom,
average
decreased
uppermost
segment
Conclusion
MGX
reduced
lipids
reducing
stasis.
Thus,
is
useful
tool
for
analyzing
MGD.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(1), P. 199 - 199
Published: Jan. 1, 2025
Objectives:
To
compare
the
long-term
efficacy
and
safety
of
intense
pulsed
light
(IPL)
treatments
using
a
590-nm
an
acne
filter.
Methods:
In
this
prospective,
randomized,
paired-eye
trial
study,
30
patients
with
moderate
severe
meibomian
gland
dysfunction
(MGD)
were
followed
up
for
at
least
one
month
after
their
last
treatment.
Group
A
received
IPL
treatment
filter,
type
notch
filter
that
blocks
wavelengths
between
600
800
nm,
allowing
to
emit
400–600
nm
800–1200
nm.
B
590
cut-off
below
Clinical
parameters,
including
tear
osmolarity,
matrix
metalloproteinase
(MMP)-9
expression,
break-up
time,
ocular
surface
staining
scores,
Schirmer’s
test
I,
lid
margin
telangiectasia
MG
expressibility/secretion
Ocular
Surface
Disease
Index
measured
baseline,
1,
6,
12
months
Results:
linear
mixed
model,
significant
time
effects
on
all
clinical
except
MMP-9
grades
I
results,
observed
within
each
group.
However,
interactions
points
(baseline,
6
months,
months)
groups
(Group
A,
B)
not
significant.
The
generalized
estimating
equation
model
showed
no
interaction
positivity;
however,
effect
positivity
was
in
decrease
when
compared
baseline
months.
Conclusions:
modality
MGD
demonstrated
therapeutic
year
under
strictly
controlled
self-administration
other
treatments.
is
promising
option
reducing
patients.
Cornea,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 14, 2025
Purpose:
To
evaluate
the
efficacy
and
safety
of
intense
pulsed
light
(IPL)
combined
with
meibomian
gland
expression
(MGX)
for
treatment
dry
eye
disease
dysfunction
associated
chronic
Stevens–Johnson
syndrome
toxic
epidermal
necrolysis.
Methods:
This
prospective
noncomparative
interventional
study
included
29
patients
(58
eyes)
who
underwent
3
sessions
IPL
MGX
at
2-week
intervals.
Subjective
symptoms
(ocular
surface
index
score)
objective
tests:
matrix
metalloproteinase
9,
tear
meniscus
height,
bulbar
redness
score,
film
lipid
layer
thickness
(LLT),
Schirmer
I
test,
conjunctival
corneal
staining,
loss,
score
[meibomian
(MGS)],
break-up
time
were
assessed
baseline
after
4,
8,
12
weeks.
Results:
Twenty-nine
individuals
(57
in
this
analysis.
The
ocular
decreased
significantly
from
60.07
±
23.34
(baseline)
to
38.36
22.39
(after
90
days)
(
P
<
0.01).
fluorescein
lissamine
green
staining
scores,
MGS,
LLT
improved
In
contrast,
there
no
significant
changes
height
values,
9
positivity,
meibography
superior
inferior
eyelids,
time.
Ocular
or
skin
complications
not
observed.
Conclusions:
Three
therapy
followed
by
seemed
be
safe
effective
treating
dysfunction,
improving
vision-related
quality
life,
symptoms,
signs,
such
as
days
Cornea,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 18, 2025
Purpose:
Meibomian
gland
dysfunction
(MGD)
is
a
global
health
disorder,
which
can
have
deleterious
effect
on
visual
function
and
quality
of
life.
Intense
pulsed
light
(IPL)
therapy
has
been
shown
to
ameliorate
MGD.
However,
the
optimal
candidates
who
would
benefit
most
from
IPL
remain
undetermined.
Therefore,
we
aimed
in
this
study
identify
clinical
factors
associated
with
favorable
outcomes
patients
MGD
after
therapy.
Methods:
This
single-center
retrospective
included
refractory
treated
course
combined
meibomian
expression,
follow-up
period
6
months.
The
outcome
measures
were
standardized
patient
evaluation
eye
dryness
(SPEED)
score,
tear
breakup
time,
lid
telangiectasia,
meibum
quality,
expressibility.
Good
responders
defined
as
those
at
least
1-point
reduction
SPEED
score
1-grade
decrease
Data
analyzed
using
t
test,
chi-square
binary
logistic
regression
analysis.
Results:
A
total
90
eyes
(good
responders:
48
eyes,
nonresponders:
42
eyes)
included.
Univariate
analysis
revealed
that
good
had
higher
baseline
than
nonresponders.
Multivariate
showed
more
severe
symptoms,
inspissated
meibum,
better
expressibility,
milder
degree
telangiectasia
independently
response.
Conclusions:
Our
findings
suggest
worse
poorer
or
less
obstruction
are
likely
response
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 15, 2022
Purpose
This
study
compared
the
changes
in
tear
inflammatory
cytokine
levels
after
intense
pulsed
light
(IPL)
combined
with
meibomian
gland
expression
(MGX)
(IPL
group)
and
instant
warm
compresses
MGX
(physiotherapy
as
treatments
for
dysfunction
(MGD)-related
dry
eye
disease
(DED)
to
explore
their
similarities
differences
therapeutic
mechanisms.
Methods
was
a
post-hoc
analysis
of
randomized
controlled
trial.
Thirteen
patients
MGD-related
DED
were
enrolled
each
group
received
three
correspondingly
3-week
intervals.
The
20
cytokines,
namely,
TNF-α,
IL-6,
MMP-9,
CXCL8/IL-8,
CXCL10/IP-10,
IL-10,
EGF,
IL-6R,
IL-1β,
IFN-γ,
lactoferrin,
Fas
ligand,
IL-17A,
LT-α,
S100A9,
LCN2/NGAL,
IL-13,
IL-12/IL-23p40,
Fas,
CCL11/Eotaxin,
measured
at
baseline,
before
second
third
treatments,
3
weeks
treatment.
primary
outcome
difference
between
baseline
last
measurement,
trends
analyzed
measurement
point.
Results
At
significant
decrease
observed
all
cytokines
both
IPL
physiotherapy
groups
baseline.
showed
greater
reductions
CCL11/Eotaxin
than
group.
Lipocalin-2/NGAL
continued
treatment
time.
Important
interactions
found
IL-6
IL-13
levels,
where
first
decreased
then
slightly
increased
treatment,
while
they
Conclusions
mechanisms
treating
associated
reducing
inflammation,
superiority
could
be
attributed
its
better
inhibitory
effect
on
like
IL-6.
In
addition,
several
downward
trend
during
suggesting
that
vicious
cycle
suppressed.
Clinical ophthalmology,
Journal Year:
2021,
Volume and Issue:
Volume 15, P. 2803 - 2811
Published: June 1, 2021
To
analyse
the
clinical
outcome
in
patients
with
meibomian
gland
dysfunction
(MGD)
who
underwent
intense
pulsed
light
(IPL)
plus
low-level
therapy
(LLL).The
prospective
non-comparative
study
included
identified
by
MGD
altered
interferometry
and
lower
loss
area
of
glands
(LAMG),
IPL
LLL,
between
July
2020
August
2020.
A
multimodal
assessment
was
performed
before,
2-3
weeks,
6
months
after
treatment.
The
main
lipid
layer
thickness
(LLT)
secondary
outcomes
were
ocular
surface
disease
index
(OSDI)
score,
presence
corneal
fluorescein
staining
(CFS),
blink
rate
(BR),
Schirmer
test
(ST),
tear
meniscus
height
(TMH),
osmolarity
(OSM),
non-invasive
break-up
time
(NIBUT)
LAMG.This
62
eyes
31
patients,
61.3%
female,
a
mean
age
66.94±9.08
years
at
LLL
LLT
(<0.001)
grades
improved
OSDI
score
(p<0.001)
from
45.02±21.17
(severe
symptoms)
to
22.35±17.68
(moderate
weeks
8.24±17.9.91
(normal)
CFS
51.6%
(32/62)
before
45.2%
(28/62)
(p=0.293)
ST
(p=0.014)
improved;
OSM
mild
worsened
(p<0.001);
TMH,
NIBUT
LAMG
did
not
modify
No
patient
suffered
any
adverse
effects.IPL
combined
effective
safe,
improving
decreasing
level
symptoms.
Clinical ophthalmology,
Journal Year:
2022,
Volume and Issue:
Volume 16, P. 3883 - 3893
Published: Nov. 1, 2022
Purpose:
To
review
the
indications
and
efficacy
of
Intense
Pulsed
Light
(IPL)
application
in
treatment
Meibomian
Gland
Dysfunction
(MGD).
Its
main
purpose
is
to
describe
its
physiology,
efficacy,
indications,
adverse
effects.
Patients
Methods:
A
two
database
(PubMed,
EMBASE)
search
was
performed
from
July
2017
2022
using
MeSH
terms
("Intense
Light"
AND
("Meibomian
Dysfunction"
OR
"Dry
Eye").
We
included
randomized
studies
systematic
reviews
with
meta-analysis.
Exclusion
criteria
were
non-randomized
trials,
enrolling
non-MGD
dry
eye
disease,
other
works
older
than
5
years.
Results:
Current
literature
shows
that
IPL
an
effective
safe
modality
for
severe
eye.
Available
evidence
improvement
symptoms
objective
indicators,
such
as
noninvasive
breakup
time,
thickness
lipid
layer,
Schirmer
test.
However,
our
concluded
beneficial
effects
may
lose
some
at
6-months
after
initial
session,
subsequent
sessions
be
required.
Thus,
should
not
considered
first-line
therapy
MGD
but
instead
adjuvant
option
standard
care.
The
optimal
remains
unknown
tailored
according
each
patient's
phenotype,
clinician's
experience,
available
technology.
There
down-regulate
pro-inflammatory
markers
(such
interleukin
(IL)
6,
IL17a,
IL-1)
Prostaglandin
E2
(PGE2).
Conclusion:
a
multifactorial
disease
seems
promising
modality.
Despite
this,
more
needed
study
benefits
–
since
this
emerging
technology,
it
expected
increase
comparative
following
years,
longer
follow-up
periods,
which
enable
precise
conclusions
about
Keywords:
meibomian
gland
dysfunction,
intense
pulsed
light,
low-level
light
therapy,
near-infrared
ocular
surface
index
Asia-Pacific Journal of Ophthalmology,
Journal Year:
2023,
Volume and Issue:
12(3), P. 315 - 325
Published: April 12, 2023
To
determine
the
efficacy
and
safety
of
eyelid
exfoliation
treatment
in
dry
eye
disease
(DED),
blepharitis,
contact
lens
(CL)
discomfort
patients.A
systematic
review
that
included
only
full-length
randomized
controlled
studies,
reporting
effects
2
databases,
PubMed
Web
Science,
was
performed
according
to
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analyses
statement.
The
search
period
between
October
29,
2022
December
6,
2022.
Cochrane
risk
bias
tool
used
analyze
quality
studies
selected.A
total
7
were
this
review.
Eyelid
influence
on
DED,
CL
analyzed
4,
respectively.
achieved
a
better
improvement
than
control
group
interventions
all
reported
variables.
mean
differences
both
groups
as
follows:
Ocular
Surface
Disease
Index
score
-5.0
±
0.9
points,
tear
breakup
time
0.43
0.2
seconds,
ocular
surface
staining
-1.4
1.5
meibomian
glands
secretions
1.2
1.1
yielding
liquid
secretion
0.6
0.3
microorganism
load
-3.2
4.7
Contact
Lens
Dry
Eye
Questionnaire-8
-2.15
0.1
points.
Minimal
(n
=
13)
irritation
2)
main
complications
after
an
treatment.Eyelid
is
safe
effective
should
be
indicated
discomfort.